UAB scientists are investigating inflammation’s role in a host of diseases and disorders.
A study led by UAB dermatologist Craig Elmets, M.D., recently reported that the non-steroidal anti-inflammatory drug (NSAID) Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have precancerous actinic keratoses lesions and are at high risk for having the disease. The researchers are now planning to investigate whether other NSAIDs may work as chemopreventive agents for skin cancer, including topical NSAIDs. Learn more about this study in a story from UAB News.
Researchers in the UAB School of Nursing are exploring the effectiveness of various inflammatory biomarkers to diagnose and predict the evolution of stroke.
Karen Gamble, Ph.D., in the UAB Department of Psychiatry, was the co-author of a 2010 paper in the Journal of Immunology that documented major inflammatory response in animal models that mimicked the day/night confusion experienced by shift workers and travelers who experience frequent jet lag, such as flight attendants. Earlier studies have found that people in these jobs have a higher risk of several different cancers, as well as gastric ulcers, obesity, diabetes, stroke, atherosclerosis, and heart attack. Learn more about Gamble's research in this feature in UAB Magazine.